Cerebellum cholinergic muscarinic receptor (subtype-2 and -3) and cytoarchitecture after developmental exposure to methylmercury: An immunohistochemical study in rat

Journal of Chemical Neuroanatomy

Volumn 35, Issue 3, 2008, Pages 285-294

  Roda, Elisa ^a   Coccini, Teresa ^b   Acerbi, Davide ^b   Castoldi, Anna ^b   Bernocchi, Graziella ^a   Manzo, Luigi ^a,b  

^a UNIVERSITY OF PAVIA   (Italy)

^b IRCCS   (Italy)

Author keywords

Gliosis; MeHg; Neurotoxicity; Puberty; Weaning

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; METHYLMERCURY; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN DEVELOPMENT; CELL COUNT; CEREBELLUM; CONTROLLED STUDY; CYTOARCHITECTURE; CYTOTOXICITY; DEVELOPMENTAL STAGE; FEMALE; GLIOSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUBERTY; PURKINJE CELL; RAT; WEANING;

ANIMALS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CEREBELLUM; COLORING AGENTS; EOSINE YELLOWISH-(YS); FEMALE; FLUORESCENT DYES; GLIAL FIBRILLARY ACIDIC PROTEIN; HEMATOXYLIN; IMMUNOHISTOCHEMISTRY; MALE; MERCURY POISONING, NERVOUS SYSTEM; METHYLMERCURY COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3;

EID: 41549087331     PISSN: 08910618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2008.01.003     Document Type: Article

References (75)

1. Altman J. Postnatal development of the cerebellar cortex in the rat. I. The external granular layer and the transitional molecular layer. J. Comp. Neurol. 145 (1972) 353-398
2. Altman J. Postnatal development of the cerebellar cortex in the rat. II. Phases in the maturation of Purkinje cells and of the molecular layer. J. Comp. Neurol. 145 (1972) 399-464
3. Altman J. Morphological development of the rat cerebellum and some of its mechanisms. Exp. Brain Res. 6 (1982) 8-46
4. Amin-zaki L., Majeed M.A., Greenwood M.R., Elhassani B.S., Clarkson T.W., and Doherry R.A. Methylmercury poisoning in the Iraqi suckling infants: a longitudinal study over five years. J. Appl. Exp. Toxicol. 1 (1981) 210-214
5. Andressen C., Blümcke I., and Celio M.R. Calcium-binding proteins: selective markers of nerve cells. Cell Tissue Res. 271 (1993) 181-208
6. Aschner M. Astrocytic swelling, phospholipase A2, glutathione and glutamate: interactions in methylmercury-induced neurotoxicity. Cell. Mol. Biol. 46 (2000) 843-854
7. Atchison W.D. Is chemical neurotransmission altered specifically during methylmercury-induced cerebellar dysfunction?. Trends Pharmacol. Sci. 26 (2005) 549-557
8. Barone Jr. S., Das K.P., Lassiter T.L., and White L.D. Vulnerable processes of nervous system development: a review of markers and methods. Neurotoxicology 21 (2000) 15-36
9. Basu N., Stamler C.J., Loua K.M., and Chan H.M. An interspecies comparison of mercury inhibition on muscarinic acetylcholine receptor binding in the cerebral cortex and cerebellum. Toxicol. Appl. Pharmacol. 205 (2005) 71-76
10. Burbacher T.M., Rodier P.M., and Weiss B. Methylmercury developmental neurotoxicity: a comparison effects in human and animals. Neurotoxicol. Teratol. 12 (1990) 191-202
11. Castoldi A.F., Candura S.M., Costa P., Manzo L., and Costa L.G. Interaction of mercury compounds with muscarinic receptor subtypes in the rat brain. Neurotoxicology 17 (1996) 735-742
12. Castoldi A.F., Coccini T., Beccatelli S., and Manzo L. Neurotoxicity and molecular effects of methylmercury. Brain Res. Bull. 55 (2001) 197-203
13. Chang L.W., Reuhl K.R., and Spyker J.M. Ultrastructural study of the latent effects of methylmercury on the nervous system after prenatal exposure. Environ. Res. 13 (1977) 171-185
14. Choi B.H. The effects of methylmercury on the developing brain. Prog. Neurobiol. 32 (1989) 447-470
15. Choi B.H., Lapham L.W., Amin-zaki L., and Saleem T. Abnormal neuronal migration, deranged cerebral cortical organization and diffuse white matter astrocytosis of human fetal brain. A major effect of methylmercury poisoning in utero. J. Neuropathol. Exp. Neurol. 37 (1978) 719-733
16. Choi B.H., Kudo M., and Lapham L.W. A Golgi and electron-microscopic study of cerebellum in methylmercury-poisoned neonatal mice. Acta Neuropathol. 54 (1981) 233-237
17. Coccini T., Randine G., Candura S.M., Nappi R., Prockop L.D., and Manzo L. Low-level exposure to methylmercury modifies muscarinic cholinergic receptor binding characteristics in rat brain and lymphocytes: physiologic implications and new opportunities in biological monitoring. Environ. Health Perspect. 108 (2000) 29-33
18. Coccini T., Randine G., Castoldi A.F., Grandjean P., Ostendorp G., Heinzow B., and Manzo L. Effects of developmental co-exposure to methylmercury and 2,2′,4,4′,5,5′-hexachlorobiphenyl (PCB153) on cholinergic muscarinic receptors in rat brain. Neurotoxicology 27 (2006) 468-477
19. Coccini T., Roda E., Castoldi A.F., Goldoni M., Poli D., Bernocchi G., and Manzo L. Perinatal co-exposure to methylmercury and PCB153 or PCB126 in rats alters the cerebral cholinergic muscarinic receptors at weaning and puberty. Toxicology 238 (2007) 34-48
20. Davis L.E., Kornfeld M., Mooney H.S., Fiedler K.J., Haaland K.Y., Orrison W.W., Cernichiari E., and Clarkson T.W. Methylmercury poisoning: long-term clinical, radiological, toxicological, and pathological studies of an affected family. Ann. Neurol. 35 (1994) 680-688
21. Doughty M.L., Delhaye-Bouchaund N., and Mariani J. Quantitative analysis of cerebellar lobulation in normal and agranular rats. J. Comp. Neurol. 399 (1998) 306-320
22. Edwards J.R., Marty M.S., and Atchison W.D. Comparative sensitivity of rat cerebellar neurons to dysregulation of divalent cation homeostasis and cytotoxicity caused by methylmercury. Toxicol. Appl. Pharmacol. 208 (2005) 222-232
23. Eldefrawi M.E., Mansour N.A., and Eldefrawi A.T. Interactions of acetylcholine receptors with organic mercury compounds. Adv. Exp. Med. Biol. 84 (1977) 449-463
24. Eto K. Pathology of Minamata disease. Toxicol. Pathol. 25 (1997) 614-623
25. Eto K. Minamata disease. Neuropathology 20 Suppl. (2000) S14-S19
26. Ferguson S.A. Neuroanatomical and functional alterations resulting from early postnatal cerebellar insults in rodents. Pharmacol. Biochem. Behav. 55 (1996) 663-671
27. Ferguson S.A., Paule M.G., and Holson R. Functional effects of methylazoxymethanol-induced cerebellar hypoplasia in rats. Neurotoxicol. Teratol. 18 (1996) 529-537
28. Fonnum F., and Lock E.A. Cerebellum as a target for toxic substances. Toxicol. Lett. 112-113 (2000) 9-16
29. Fortin M., Marchand R., and Parent A. Calcium-binding proteins in primate cerebellum. Neurosci. Res. 30 (1998) 155-168
30. Gimenéz-Llort L., Ahlbom E., Daré E., Vahter M., Ogren A.-O., and Ceccatelli S. Prenatal exposure to methylmercury changes dopamine-modulated motor activity during early ontogeny: age- and gender-dependent effects. Environ. Toxicol. Pharmacol. 9 (2001) 61-70
31. Grammas P., Diglio C.A., Marks B.H., Giacomelli F., and Wiener J. Identification of muscarinic receptors in rat cerebral cortical microvessels. J. Neurochem. 40 (1983) 645-651
32. Grandjean P., Weihe P., White R.F., Debes F., Araki S., Yokoyama K., Murata K., Sorensen N., Dahl R., and Jorgensen P.J. Cognitive deficit in 7-year old children with prenatal exposure to methylmercury. Neurotoxicol. Teratol. 19 (1997) 417-428
33. Harada M. Congenital Minamata disease: intrauterin methylmercury poisoning. Teratology 18 (1978) 285-288
34. Ho G., Zhang C., and Zhuo L. Non-invasive imaging of gliosis in transgenic mice for profiling developmental neurotoxicity. Toxicol. Appl. Pharmacol. 221 (2007) 76-85
35. Hohmann C.F., and Berger-Sweeney J. Cholinergic regulation of cortical development and plasticity. New twists to an old story. Perspect. Dev. Neurobiol. 5 (1998) 401-425
36. Hrdina P.D., Peters D.A., and Singhal R.L. Effects of chronic exposure to cadmium, lead and mercury of brain biogenic amines in the rat. Res. Commun. Chem. Phatol. Pharmacol. 15 (1976) 483-493
37. Jaarsma D., Levey A.I., Frostholm A., Rotter A., and Voogd J. Light-microscopy distribution and parasagittal organisation of muscarinic receptors in rabbit cerebellar cortex. J. Chem. Neuroanat. 9 (1995) 241-259
38. Jaarsma D., Ruigrok T.J., Caffe R., Cozzari C., Levey A.I., Mugnaini E., and Voogd J. Cholinergic innervation and receptors in the cerebellum. Prog. Brain Res. 114 (1997) 67-96
39. Kakita A., Wakabayashi M., Su K., Sakamoto M., Ikuta F., and Takahashi H. Distinct pattern of neuronal degeneration in the fetal rat brain induced by consecutive transplacental administration of methylmercury. Brain Res. 859 (2000) 233-239
40. Kobayashi H., Yuyama A., Matsusaka N., Takeno K., and Yanagiya I. Effects of methylmercury chloride on various cholinergic parameters in vitro. J. Toxicol. Sci. 4 (1979) 351-362
41. La Farga M., Andres M.A., Calle E., and Berciano M.T. Reactive gliosis of immature Bergmann glia and microglial cell activation in response to cell death of granule cell precursor induced by methylazoxymethanol treatment in developing rat cerebellum. Anat. Embryol. 198 (1998) 111-122
42. Lapham L.W., Cernichiari E., Cox C., Myers G.J., Baggs R.B., Brewer R., Shamlaye C.F., Davidson P.W., and Clarkson T.W. An analysis of autopsy brain tissue from infants prenatally exposed to methylmercury. Neurotoxicology 16 (1995) 689-704
43. Levine R.R., Birdsall N.J.M., and Nathanson N.M. Proceedings of the Ninth International Symposium on Subtypes of Muscarinic Receptors. Life Sci. 68 (2001) 2449-2642
44. Leyshon K., and Morgan A.J. An integrated study of the morphological and gross-elemental consequences of methyl mercury intoxication in rats, with particular attention to the cerebellum. Scan. Microsc. 5 (1991) 895-904
45. Leyshon-Sorland K., Jasani B., and Morgan A.J. The localization of mercury and metallothionein in the cerebellum of rats experimentally exposed to methylmercury. Histochem. J. 26 (1994) 161-169
46. Limke T.L., Heidemann S.R., and Atchison W.D. Disruption of intraneuronal divalent cation regulation by methylmercury: are specific targets involved in altered neuronal development and cytotoxicity in methylmercury poisoning?. Neurotoxicology 25 (2004) 741-760
47. Markowski V.P., Flaugher C.B., Baggs R.B., Rawleigh R.C., Cox C., and Weiss B. Prenatal and lactational exposure to methylmercury affects select parameters of mouse cerebellar development. Neurotoxicology 19 (1998) 879-892
48. Matzumoto H., Koya G., and Takeuchi T. Fetal Minamata disease. A neuropathological study of two cases of intrauterine intoxication by a methylmercury compound. J. Neuropathol. Exp. Neurol. 24 (1965) 563-574
49. Moro V., Kacem K., Springhetti V., Seylaz J., and Lasbennes F. Microvessels isolated from brain: localization of muscarinic sites by radioligand binding and immunofluorescent techniques. J. Cereb. Blood Flow Metab. 15 (1995) 1082-1092
50. Neustadt A., Frostholm A., and Rotter A. Topographical distribution of muscarinic cholinergic receptors in the cerebellar cortex of the mouse, rat, guinea pig, and rabbit: a species comparison. J. Comp. Neurol. 272 (1988) 317-330
51. NRC. National Research Council: Toxicological Effects of Methylmercury (2000), National Academy Press, Washington, DC p. 344
52. O'Callagan J.P. Neurotypic and gliotypic proteins as biochemical markers of neurotoxicity. Neurotoxicol. Teratol. 10 (1988) 445-452
53. Pedersen M.B., Hansen J.C., Mulvad g., Pedersen H.S., Gregersen M., and Danscher G. Mercury accumulation in populations exposed to high and low dietary levels of methyl mercury. Concentration, chemical form and distribution of mercury in brain samples from autopsies. Int. J. Circumpolar Health 58 (1999) 96-107
54. Rice D., and Barone Jr. S. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ. Health Perspect. 108 (2000) 511-533
55. Roegge C.S., and Schantz S.L. Motor function developmental exposure to PCBs and/or MeHg. Neurotoxicol. Teratol. 28 (2006) 260-277
56. Roegge C.S., Morris J.R., Villareal S., Wang V.C., Powers B.E., Klintsova A.Y., Greenough W.T., Pessah I.N., and Schantz S.L. Purkinje cell and cerebellar effects following developmental exposure to PCBs and/or MeHg. Neurotoxicol. Teratol. 28 (2006) 74-85
57. Rossi A.D., Ahlbom E., Ogren S.O., Nicotera P., and Ceccatelli S. Prenatal exposure to methylmercury alters locomotor activity of male but not female rats. Brain Res. 117 (1997) 428-436
58. Sager P.R., Aschner M., and Rodier P.M. Persistent, differential alterations in developing cerebellar cortex of male and female mice after methylmercury exposure. Brain Res. 314 (1984) 1-11
59. Sakamoto M., Nakano A., Kajiwara Y., Naruse I., and Fujisaki T. Effects of methyl mercury in postnatal developing rats. Environ. Res. 61 (1993) 43-50
60. Sakamoto M., Wakabayashi K., Kakita A., Hitoshi T., Adachi T., and Nakano A. Widespread neuronal degeneration in rats following oral administration of methylmercury during the postnatal developing phase: a model of fetal-type Minamata disease. Brain Res. 784 (1998) 351-354
61. Sakamoto M., Kakita A., Wakabayashi K., Hitoshi T., Nakano A., and Akagi H. Evaluation of changes in methylmercury accumulation in the developing rat brain and its effects: a study with consecutive and moderate dose exposure throughout gestation and lactation periods. Brain Res. 949 (2002) 51-59
62. Sakamoto M., Kakita A., Bezerra de Oliveira R., Pan H.S., and Takahashi H. Dose-dependent effects of methylmercury administered during neonatal brain spurt in rats. Dev. Brain Res. 152 (2004) 171-176
63. Sato A., Sato Y., and Uchida S. Regulation of cerebral cortical blood flow by the basal forebrain cholinergic fibers and aging. Auton. Neurosci. 96 (2002) 13-19
64. Tang J., Carr R.L., and Chambers J.E. The effects of repeated oral exposure to methyl parathion on rat brain cholinesterase and muscarinic receptors during postnatal development. Toxicol. Sci. 76 (2003) 400-406
65. Takeuchi T. Pathology of Fetal Minamata disease: the effect of methylmercury on human intrauterine life. Paediatrician 6 (1977) 69-87
66. Takeuchi T. Pathology of Fetal Minamata disease, with special reference to its pathogenesis. Acta Pathol. Jpn. 32 Suppl. 1 (1982) 73-99
67. Takeuchi T., Eto K., and Tokunaga H. Mercury level and histochemical distribution in a human brain with Minamata disease following a long-term clinical course of 26 years. Neurotoxicology 10 (1989) 651-657
68. Tsuzuki Y. Effect of chronic methylmercury exposure on activities of neurotransmitter enzymes in rat cerebellum. Toxicol. Appl. Pharmacol. 60 (1981) 379-381
69. USEPA, 2001. Available: http://www.epa.gov/Region5/air/mercury/understanding.html.
70. Volpicelli L.A., and Levey A.I. Muscarinic acethylcholine receptor subtypes in cerebral cortex and hippocampus. Prog. Brain Res. 145 (2004) 59-66
71. Von Burg R., Northington F.K., and Shamoo A. Methylmercury inhibition of rat brain muscarinic receptors. Toxicol. Appl. Pharmacol. 53 (1980) 285-292
72. Wakabayashi K., Kakita A., Sakamoto M., Su M., Iwanaga K., and Ikuta F. Variability of brain lesions in rats administered methylmercury at various postnatal developmental phases. Brain Res. 705 (1995) 267-272
73. Wess J. Novel insights into muscarinic acetylcholine receptor function using gene targeting technology. Trends Pharmacol. Sci. 24 (2003) 414-420
74. Worley P.F., Baraban J.M., and Snyder S.H. Inositol 1,4,5-trisphosphate receptor binding: autoradiographic localization in rat brain. J. Neurosci. 9 (1989) 339-346
75. 2+ increases spontaneous synaptic current frequency in rat cerebellar slices. Mol. Pharmacol. 71 (2007) 1021-1109